Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-500
Closed -$8K 93
2024
Q4
$8K Sell
500
-500
-50% -$18K ﹤0.01% 78
2024
Q3
$119K Buy
+1,000
New +$40.9K 0.03% 88
2024
Q2
Sell
-1,000
Closed -$265K 93
2024
Q1
$265K Buy
+1,000
New +$41.2K 0.07% 78
2023
Q4
Sell
-1,000
Closed -$160K 85
2023
Q3
$160K Buy
+1,000
New +$35.5K 0.05% 82
2023
Q2
Sell
-500
Closed -$76K 97
2023
Q1
$76K Buy
+500
New +$17.5K 0.02% 93

Other funds holding GSK

Canal Insurance Company's GSK Position: Q2 2025 in Review

Canal Insurance Company sold out of GSK (GSK) in Q2 2025, closing a stake of 200,000 shares — an estimated $7.75M sold.

Canal Insurance Company first reported a position in GSK in Q2 2021 and held it in 16 quarters. The position peaked at $8.68M in Q1 2024. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Canal Insurance Company reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Canal Insurance Company sold 200,000 GSK shares in Q2 2025, an estimated $7.75M.
  • Canal Insurance Company first reported a position in GSK in Q2 2021 and held it in 16 quarters.
  • Canal Insurance Company's GSK position peaked at $8.68M in Q1 2024.
  • 891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Canal Insurance Company's 13F filing for Q2 2025, filed 30 Jul 2025.